Jeena Sikho Lifecare Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, alongside the recommendation of a final dividend of Rs. 4.50 per equity share. The board meeting also included the re-appointment of M/s Forvis Mazars LLP as the company’s internal auditor for the financial year 2026-27.

The company reported a standalone revenue from operations of Rs. 21,555.07 lacs for the quarter ended March 31, 2026, compared to Rs. 22,156.47 lacs in the previous quarter and Rs. 13,925.06 lacs in the corresponding quarter of the previous year. The standalone net profit after tax stood at Rs. 4,535.18 lacs for the quarter ended March 31, 2026, against Rs. 6,672.67 lacs in the previous quarter and Rs. 2,633.97 lacs in the corresponding quarter of the previous year.

Jeena Sikho Lifecare Limited is engaged in the healthcare sector, specifically focusing on Ayurveda-based clinics and hospitals, with a mission to provide freedom from diseases and drugs. The company has been expanding its operations, including through international ventures and strategic investments in healthcare entities.